Article
Causal role of EPA on ischemic heart disease, triglyceride rich lipoproteins and related traits: A two-sample Mendelian randomization analysis
2026-04-29
Abstract excerpt
<h4>ABSTRACT</h4> <h4>INTRODUCTION</h4> Most randomized controlled trials (RCTs) found that omega-3 fatty acids have little to no effect on cardiovascular disease risk. However, a few suggested that a specific omega-3 fatty acid, eicosapentaenoic acid (EPA), reduces cardiovascular disease risk in patients with high triglycerides (TG). It is unclear whether EPA is beneficial in the general population or how it af...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d2e0a058-bad5-5b90-af10-41754f5d037d
- DOI
- 10.64898/2026.04.27.26351885
